Trial Profile
A randomised open-label trial comparing highly purified human menopausal gonadotropins (hMG) and recombinant follicular stimulating hormone (rFSH) in a gonadotrophin releasing hormone (GnRH) agonist cycle for infertile women to improve pregnancy rates
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Menotropin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 21 Mar 2012 New trial record